Target intelligence / Profile preview

Mitochondrial ribosomal protein S16 pseudogene 3 (MRPS16P3)

Target
MRPS16P3
Molecular classification
Other (pseudogene)
01

Overview

Mitochondrial ribosomal protein S16 pseudogene 3 (MRPS16P3) is a pseudogene located in the human genome. Unlike its parent gene MRPS16, which encodes a component of the mitochondrial ribosome involved in mitochondrial protein synthesis, MRPS16P3 does not code for a functional protein. Pseudogenes such as MRPS16P3 are often considered non-functional genomic elements, though in some cases they may regulate their parent gene or act as miRNA decoys. No direct evidence links MRPS16P3 to any disease, therapeutic target, or known biological pathway. MRPS16P3 is categorized as a "pseudogene" and not as a classical molecular target for drugs or therapies[4][5][8]. Key points: - MRPS16P3 is distinctly classified as a pseudogene, not a protein-coding gene, enzyme, transporter, receptor, or other commonly druggable target class[4][8]. - There is no evidence that MRPS16P3 serves as a biomarker or is involved in any disease process, nor does it have characterized drug interactions or mechanisms of action[4]. - Although some pseudogenes have regulatory functions, such as competing for miRNA binding or affecting mRNA stability, there is no published evidence that MRPS16P3 performs such roles[5].

Other names
MRPS16P3 pseudogene 3MRPS16P3mitochondrial ribosomal protein S16 pseudogene 3
02

Mechanism of action

None

03

Biological functions

No direct biological function as a protein-coding gene; being a pseudogene, potential regulatory roles in gene expression (e.g., miRNA decoy activity, regulation of parent gene mRNA stability) are possible, but specific functions for MRPS16P3 are not established
04

Disease associations

None established for MRPS16P3 specifically; other pseudogenes can have regulatory effects in disease, but there is no evidence for MRPS16P3
05

Safety considerations

None
06

Biomarkers

None known

Beyond the preview

Go deeper on Mitochondrial ribosomal protein S16 pseudogene 3 (MRPS16P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosomal protein S16 pseudogene 3 (MRPS16P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call